Pfizer has officially thrown its hat in the weight-loss ring. The company’s GLP-1 receptor agonist, danuglipron, showed promise in an ongoing pharmacokinetic study, it announced Thursday. Pfizer plans ...
Pfizer is steering much of its pandemic revenue into oncology, as Chief Executive Albert Bourla says the company is betting big on cancer breakthroughs. He also voiced a personal belief that cures for ...
The FINANCIAL — Pfizer and WM Healthcare Solutions, Inc., a subsidiary of Waste Management jointly announced the introduction of a new, free-of-charge, online pharmaceutical disposal guide for health ...